U.S. Professional Services Stock News

NasdaqGS:AAL
NasdaqGS:AALAirlines

American Airlines Profit Reset Highlights Sector Risks And Potential Rewards

IATA lowers its global airline profit outlook, citing pressure on sector-wide earnings. American Airlines Group (NasdaqGS:AAL) cuts its own profit expectations in response to higher fuel costs. Geopolitical conflicts in the Middle East add operational disruptions and further cost uncertainty for the carrier. American Airlines Group, one of the largest U.S. carriers, is adjusting to a tougher industry backdrop as IATA revises profit expectations for airlines globally. For investors, the...
NasdaqGS:VFS
NasdaqGS:VFSAuto

VinFast Auto (NasdaqGS:VFS) Q1 Loss Of ₫28.1t Tests Growth Heavy Bull Narratives

VinFast Auto (NasdaqGS:VFS) opened 2026 with Q1 revenue of about ₫23.1 trillion (₫23,111,052 million) and a net loss of roughly ₫28.1 trillion (₫28,059,960 million), translating to a basic EPS loss of ₫11,993.81. The trailing 12 months show revenue of around ₫96.98 trillion and a net loss of about ₫109.77 trillion, or EPS of ₫46,924.97. Over recent quarters the company has seen revenue range from approximately ₫16.3 trillion in Q1 2025 to ₫39.16 trillion in Q4 2025, with basic EPS losses...
NYSE:IP
NYSE:IPPackaging

International Paper Rail Hub Project Tests Valuation Gap And Dividend Risks

International Paper is partnering with Canadian Pacific Kansas City on a new 468,000-square-foot packaging facility in Mississippi. The site is planned with direct rail access to support inbound materials and outbound shipments across North America. The facility is expected to be operational in Q4 2027 as part of International Paper's broader transformation in packaging and logistics. For investors watching NYSE:IP, this project comes amid a mixed share performance backdrop. The stock...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Braze (BRZE) Valuation Check After Strong Q1 Beat And Post‑Earnings Share Price Decline

Braze (BRZE) stock came into focus after first quarter results showed sales of US$211 million, a smaller net loss, and guidance for higher revenue, even though the shares fell following the report. See our latest analysis for Braze. At a share price of US$23.07, Braze has seen a 23.43% 90 day share price return but is down 29.12% year to date, with a 1 year total shareholder return that declined 24.73%. This suggests recent momentum has firmed up following a weaker stretch. If you are looking...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

Regencell Bioscience Holdings (RGC) Is Down 11.5% After DOJ Subpoena Spurs Class Actions Over Alleged Misstatements – Has The Bull Case Changed?

In the past, several law firms, including Levi & Korsinsky, Rosen Law Firm and Holzer & Holzer, announced securities class action lawsuits against Regencell Bioscience Holdings after the company disclosed a Department of Justice subpoena into trading of its ordinary shares. The cases focus on allegations that Regencell issued materially false or misleading statements and failed to disclose its vulnerability to market manipulation during the October 28, 2024 to October 31, 2025 period...
NYSE:REXR
NYSE:REXRIndustrial REITs

Is It Time To Reassess Rexford Industrial Realty (REXR) After Its Prolonged Share Price Weakness

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

How A Potential Eight-Year Grand Canyon University Contract Extension At Grand Canyon Education (LOPE) Has Changed Its Investment Story

Grand Canyon Education recently disclosed that it is in discussions with Grand Canyon University to amend their Master Services Agreement, potentially extending the partnership by eight years and revising how service fees are calculated. This contract review matters because it could reshape Grand Canyon Education’s revenue mix, concentration risk, and long-term reliance on its largest university partner. We’ll now examine how the potential eight-year extension of the Grand Canyon University...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Should Tandem’s Expanded EU Diabetes Indications and ESOP Shelf Filing Require Action From Tandem Diabetes Care (TNDM) Investors?

In May 2026, Tandem Diabetes Care filed a US$47.40 million shelf registration for 3,260,000 common shares linked to its employee stock ownership plan and separately secured CE mark approval in Europe to extend use of its t:slim X2 and Tandem Mobi automated insulin delivery systems to pregnancy in type 1 diabetes and adults with type 2 diabetes. This broader European certification opens access to new patient groups and care settings, potentially reinforcing Tandem’s role within integrated...
NasdaqGM:MDB
NasdaqGM:MDBIT

MongoDB (MDB) Valuation Check After Raised Guidance And Interest Rate Pressure On Growth Stocks

MongoDB (MDB) recently reported first quarter results and raised its full year 2027 revenue and earnings guidance, even as higher for longer interest rate expectations pressured growth stocks in broader trading. See our latest analysis for MongoDB. MongoDB's share price has been volatile recently, with a 7 day share price return down 12.71%, yet a 30 day share price return of 17.73% and a 90 day share price return of 30.31% hinting at rebuilding momentum despite a year to date share price...
NYSE:LOMA
NYSE:LOMABasic Materials

Assessing Loma Negra (NYSE:LOMA) Valuation After Recent Share Price Weakness And Premium P/E Multiple

Recent share performance and business scale Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has seen its stock decline 14.7% year to date, while the past 3 months show a gain of 4.4% and the month is broadly flat. For context on the underlying business, the company reports revenue of roughly $850,476.19 and net income of about $36,113.48. Its operations span cement, concrete, aggregates, railway services and other related activities in Argentina. See our latest analysis for...
NasdaqCM:HBNB
NasdaqCM:HBNBReal Estate

A Look At Hotel101 Global Holdings (NasdaqCM:HBNB) Valuation After Recent Share Price Weakness

Why Hotel101 Global Holdings Stock Is Drawing Attention Now Hotel101 Global Holdings (NasdaqCM:HBNB) has been drawing attention after a period of weak share performance, with the stock down 8% over the past month and 33% over the past 3 months. For investors, the recent slide sits alongside a market value of about US$1.32b, revenue of US$75.87 million from property development, and a net loss of US$26.71 million. This combination is prompting a closer look at the business model. See our...
NasdaqGS:YSWY
NasdaqGS:YSWYConsumer Retailing

Evaluating Yesway (YSWY) After Recent Share Weakness And A Deep Discount To Estimated Fair Value

Yesway (YSWY) is drawing attention after its recent share performance, with the stock down about 15% over the past month following a modest single-day and past-week decline. See our latest analysis for Yesway. That 14.6% decline in the 30 day share price return, alongside a small year to date share price gain of 3.7% with the stock now at US$22.01, suggests recent momentum has cooled after a firmer start to the year. If you are looking beyond Yesway and want ideas with a similar risk on...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

A Look At Celcuity (CELC) Valuation After Positive VIKTORIA-1 Data And FDA Priority Review

Celcuity (CELC) has moved into focus after reporting Phase 3 VIKTORIA-1 data for gedatolisib and securing FDA Priority Review, alongside a newly priced US$500 million convertible senior notes offering due 2032. See our latest analysis for Celcuity. Despite the positive Phase 3 VIKTORIA-1 data and FDA Priority Review, Celcuity’s share price has pulled back sharply in recent weeks, with a 30 day share price return of down 33.3%, even as the 1 year total shareholder return is very large and...
NYSE:EVTC
NYSE:EVTCDiversified Financial

Does EVERTEC's (EVTC) Third-Party Data Scare Reveal a Deeper Vendor-Risk Trade-Off?

Evertec recently disclosed that it had detected potential unauthorized access to customer data via a third-party support platform used by financial institution clients, primarily in Puerto Rico, and has begun investigation and containment efforts without reporting any service interruptions. This incident highlights how operational reliance on external technology vendors can introduce data security vulnerabilities that matter for both customers and investors. We’ll now examine how this...
NYSE:JXN
NYSE:JXNDiversified Financial

How Jackson’s New Notes Offering and RILA Launch Could Reshape Jackson Financial’s (JXN) Investor Story

Jackson Financial Inc. recently completed a US$748.73 million fixed-rate senior unsecured notes offering, issuing 6.150% callable notes due January 15, 2037 at a slight discount to par. At the same time, Jackson’s launch of new registered index-linked annuities with added index options and funding flexibility highlights an effort to broaden and modernize its retirement income lineup. Next, we’ll examine how this combination of new RILA features and fresh long-term funding could shape Jackson...
NYSE:EHC
NYSE:EHCHealthcare

Will Encompass Health’s (EHC) Debt Refinance and New Hospital Plan Shift Its Growth-Leverage Narrative

Encompass Health recently completed a US$500,000,000 private offering of 5.875% senior notes due 2034, primarily to refinance existing 4.500% 2028 notes, repay revolving credit facility borrowings, and cover related fees, while also opening plans for a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia to replace a closed 19-bed unit. This combination of balance sheet reshaping through longer-dated, higher-coupon unsecured debt and continued investment in specialized...
NYSE:FNF
NYSE:FNFInsurance

Will FNF's Revenue Growth But Earnings Miss Shift Fidelity National Financial's Core Investment Narrative?

In its latest quarterly update, Fidelity National Financial reported US$3.23 billion in revenue, an 18.2% year-on-year increase that nonetheless fell short of analyst expectations for both sales and earnings per share. This combination of growth and an earnings miss highlighted a gap between the company’s recent operating performance and the projections embedded in prior analyst models. Now we will consider how this revenue and EPS shortfall against expectations affects Fidelity National...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker’s Index Debut And Google Tie-Up Reframe Growth Story

Warby Parker (NYSE:WRBY) has been added to the S&P SmallCap 600 index, a move that can influence its visibility with index funds and institutional investors. The company also announced a partnership with Google to develop AI-powered intelligent eyewear, bringing smart functionality to its consumer eyewear offering. Warby Parker operates across omnichannel retail and e-commerce, selling prescription glasses, sunglasses, contacts and related eye care services. The S&P SmallCap 600 addition...
NYSE:CBAN
NYSE:CBANBanks

Undervalued Stock Opportunities Based On Market Estimates In June 2026

Over the last 7 days, the United States market has experienced a 2.7% drop, though it has risen by 23% over the past year, with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying undervalued stocks can present opportunities for investors seeking to capitalize on potential growth and favorable market estimates.
NYSE:RYAN
NYSE:RYANInsurance

ATRenew And Two Insider-Favored Growth Stocks To Watch

Over the last 7 days, the United States market has dropped 2.7%, yet it has shown resilience with a 23% rise over the past year and expectations for earnings to grow by 17% annually in the coming years. In this context, growth companies with high insider ownership, such as ATRenew and two others we'll explore, can be particularly appealing as they often indicate strong internal confidence in their long-term potential.
NYSE:GROV
NYSE:GROVSpecialty Retail

3 Promising Penny Stocks With At Least $40M Market Cap

Over the last 7 days, the United States market has dropped 2.7%, but it has risen by 23% in the past year, with earnings forecasted to grow by 17% annually. For investors willing to explore beyond well-known stocks, penny stocks—though a somewhat outdated term—still represent an intriguing investment area due to their affordability and potential for growth. This article highlights three penny stocks that stand out for their financial strength and resilience, offering compelling opportunities...
NasdaqGS:ARTN.A
NasdaqGS:ARTN.AWater Utilities

Top Dividend Stocks To Consider In June 2026

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 23% over the past year with earnings forecasted to grow by 17% annually. In such dynamic conditions, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking stability and income.
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

Apogee Therapeutics (APGE) Valuation Check After Positive Phase 2 APEX Data And US$1.3b Blackstone Financing

Apogee Therapeutics (APGE) stock is in focus after positive 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis, followed by a milestone-based, non-dilutive financing package of up to US$1.3b from Blackstone Life Sciences. See our latest analysis for Apogee Therapeutics. After a sharp rally tied to the Phase 2 APEX data and US$1.3b Blackstone financing, Apogee’s share price has eased 4.5% over the last day, although the 1-year total shareholder return of 106.85% points to strong...
NYSE:GRDN
NYSE:GRDNHealthcare

Is Guardian’s Expanded Credit Facility Reshaping the Investment Case for Guardian Pharmacy Services (GRDN)?

In May 2026, Guardian Pharmacy Services, Inc. entered into an eighth amendment to its long-standing loan and security agreement, extending the revolving credit facility’s maturity to May 21, 2030, expanding potential borrowing capacity to US$80 million, and updating covenants to a consolidated net leverage ratio framework. This refinancing package gives Guardian more room to manage debt against cash and Adjusted EBITDA, which may influence how investors assess its balance sheet flexibility...